Edition:
United Kingdom

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

27.51USD
19 Jun 2019
Change (% chg)

$-0.38 (-1.36%)
Prev Close
$27.89
Open
$27.98
Day's High
$28.16
Day's Low
$27.29
Volume
933,116
Avg. Vol
742,191
52-wk High
$28.16
52-wk Low
$10.41

Latest Key Developments (Source: Significant Developments)

Arrowhead Pharmaceuticals Reports Qtrly Earnings Per Share $0.24
Wednesday, 8 May 2019 

May 8 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS REPORTS FISCAL 2019 SECOND QUARTER RESULTS.QTRLY EARNINGS PER SHARE $0.24.QTRLY REVENUE$48.2 MILLION VERSUS $650,125.Q2 EARNINGS PER SHARE VIEW $0.19, REVENUE VIEW $43.0 MILLION -- REFINITIV IBES DATA.  Full Article

Arrowhead Pharmaceuticals Earns $25 Million Milestone Payment From Janssen
Wednesday, 24 Apr 2019 

April 24 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD BEGINS TRIPLE COMBINATION COHORT IN CHRONIC HBV PATIENTS AND EARNS $25 MILLION MILESTONE PAYMENT FROM JANSSEN.ARROWHEAD - BEGUN DOSING IN NEW TRIPLE COMBINATION COHORT THAT INCLUDES JNJ-3989 AND ADDITIONAL UNDISCLOSED AGENTS SELECTED BY JANSSEN PHARMACEUTICALS.ARROWHEAD - ELIGIBLE TO RECEIVE REMAINING $25 MILLION UPON INITIATION OF A PHASE 2 STUDY BY JANSSEN.  Full Article

Arrowhead Pharmaceuticals Inc Quarterly Loss Per Share $0.12
Tuesday, 11 Dec 2018 

Dec 11 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS INC QUARTERLY LOSS PER SHARE $0.12.ARROWHEAD PHARMACEUTICALS INC QUARTERLY REVENUES $11.26 MILLION VERSUS $8.7 MILLION.  Full Article

Arrowhead Pharmaceuticals Inc Files For Offering Of Up To 3.3 Mln Shares Of Common Stock
Thursday, 29 Nov 2018 

Nov 29 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS INC FILES FOR OFFERING OF UP TO 3.3 MILLION SHARES OF COMMON STOCK - SEC FILING.  Full Article

Arrowhead Pharmaceuticals Quarterly Net Loss Per Share $0.18
Tuesday, 7 Aug 2018 

Aug 7 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS REPORTS FISCAL 2018 THIRD QUARTER RESULTS.ARROWHEAD PHARMACEUTICALS INC QUARTERLY NET LOSS PER SHARE $0.18.ARROWHEAD PHARMACEUTICALS INC QUARTERLY REVENUE $727,375 VERSUS $9.34 MILLION.  Full Article

Arrowhead Pharmaceuticals Earns $10 Mln Milestone Payment From Amgen
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS SAYS EARNED $10 MILLION MILESTONE PAYMENT FROM AMGEN FOLLOWING ADMINISTRATION OF FIRST DOSE OF AMG 890.  Full Article

Arrowhead Pharmaceuticals Presents Preclinical Data On Expanding Cardiometabolic Pipeline
Friday, 11 May 2018 

May 11 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS PRESENTS PRECLINICAL DATA ON EXPANDING CARDIOMETABOLIC PIPELINE.ARROWHEAD PHARMACEUTICALS - INTENDS TO FILE CLINICAL TRIAL APPLICATIONS FOR ARO-ANG3 & ARO-APOC3 BEFORE END OF 2018.  Full Article

Arrowhead Pharmaceuticals Reports Qtrly Loss Per Share $0.18
Tuesday, 8 May 2018 

May 8 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS REPORTS FISCAL 2018 SECOND QUARTER RESULTS.QTRLY LOSS PER SHARE $0.18.Q2 EARNINGS PER SHARE VIEW $-0.19 -- THOMSON REUTERS I/B/E/S.  Full Article

Arrowhead Pharmaceuticals Announces Pricing Of Underwritten Public Offering Of Common Stock
Thursday, 18 Jan 2018 

Jan 18 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS ANNOUNCES PRICING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 10.0 MILLION COMMON SHARES PRICED AT $5.25PER SHARE.  Full Article

Arrowhead Pharma Announces Proposed Underwritten Offering Of Common Stock
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS ANNOUNCES PROPOSED UNDERWRITTEN OFFERING OF COMMON STOCK.  Full Article